Literature DB >> 20811171

Successful percutaneous management of acute left ventricular assist device stoppage.

George S Chrysant1, Douglas A Horstmanshof, Trevor Snyder, John S Chaffin, C Craig Elkins, Paul J Kanaly, James W Long.   

Abstract

The HeartMate II left ventricular assist device (LVAD) is a small axial-flow next-generation pump. Acute stoppage of this device is a potentially lethal complication. As these devices proliferate, many patients will be in areas remote to their implant center. Therefore, percutaneous stabilization of these patients before definitive surgical replacement could be potentially life saving. We present two cases of acute LVAD stoppage managed successfully using percutaneous means.

Entities:  

Mesh:

Year:  2010        PMID: 20811171     DOI: 10.1097/MAT.0b013e3181ed937f

Source DB:  PubMed          Journal:  ASAIO J        ISSN: 1058-2916            Impact factor:   2.872


  2 in total

Review 1.  Percutaneous Transcatheter Therapies for the Management of Left Ventricular Assist Device Complications.

Authors:  Rohan J Kalathiya; Jonathan Grinstein; Nir Uriel; Atman P Shah
Journal:  J Invasive Cardiol       Date:  2017-02-15       Impact factor: 2.022

2.  Left Ventricular Assist Device Deactivation via Percutaneous Closure of the Outflow Graft.

Authors:  Jonathan Grinstein; Jeremy Estrada; Gabriel Sayer; Gene H Kim; Nitasha Sarswat; Sirtaz Adatya; Sandeep Nathan; Jonathan D Paul; John E A Blair; Valluvan Jeevanandam; Roberto Lang; Nir Uriel; Atman P Shah
Journal:  J Card Fail       Date:  2016-06-09       Impact factor: 5.712

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.